• Users Online: 105
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe News Contacts Login 
Year : 2020  |  Volume : 4  |  Issue : 2  |  Page : 40-44

Pharmacologic prevention of delirium after cardiac surgery: Current best available evidence

Department of Cardiac Surgery, Harefield Hospital, London, England

Correspondence Address:
Dr. Shahzad G Raja
Department of Cardiac Surgery, Harefield Hospital, London
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/hm.hm_9_20

Rights and Permissions

Delirium is a familiar neuropsychological syndrome confronted after cardiac surgery associated with a significant morbidity and mortality. Although several therapeutic options including dexamethasone, rivastigmine, risperidone, ketamine, dexmedetomidine, propofol, and clonidine have been used for delirium prevention, there is still lack of certainty regarding the most effective drug. In the current era of evidence-based medicine, the systematic review (with homogeneity) of randomized controlled trials is regarded as the most precise tool for determining the benefit of a therapeutic intervention. This review article aims to assess the current best available evidence to determine the most effective pharmacologic agent for prevention of delirium post cardiac surgery.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1693    
    Comments [Add]    

Recommend this journal